The prospect of orally administered monoclonal secretory IgA (SIgA) antibodies to prevent enteric bacterial infections

Eliminating diarrheal diseases as a leading cause of childhood morbidity and mortality in low- and middle-income countries (LMICs) will require multiple intervention strategies. In this review, we spotlight a series of preclinical studies investigating the potential of orally administered monoclonal...

Full description

Bibliographic Details
Published in:Human Vaccines & Immunotherapeutics
Main Authors: Angelene Richards, Danielle Baranova, Nicholas J. Mantis
Format: Article
Language:English
Published: Taylor & Francis Group 2022-04-01
Subjects:
Online Access:http://dx.doi.org/10.1080/21645515.2021.1964317